The Europe orthopedic market is anticipated to grow $21966 million by 2024. The market growth is expected at the CAGR of 5.94% in the forecast period. The base year considered for the market study is 2016. Acceleration in the cases of musculoskeletal disorders and growing geriatric population are the reason for the growth of the orthopedic market in the region.
The Europe orthopedic market is segmented on the basis of procedure, ortho biologics, and geography. The Europe orthopedic market by the procedure is segmented into arthroscopy, joint reconstruction, HIP, knee, shoulder reconstruction market, soft tissue replacement, spinal surgery procedure. The market by ortho biologics is further segmented into the bone graft, viscosupplementation, one-injection, three-injection, five- injection, stem cells, bone morphogenetic proteins, demineralized bone matrix, allografts and others. The Europe orthopedic market is further segmented into UK, France, Germany, Spain, Italy and rest of Europe. Improved Implant Technologies, increasing Number of Outpatient Techniques, growing Trauma Related Injuries, Age Related Orthopedic Surgeries, increasing Demand for the Elective procedure are the major drivers driving the Orthopedics market. On the other hand, factors restricting the market growth are Stringent Government Policies, Post-Surgery Complications. Growing disposable income across the world is also estimated to be one of the major factors that are creating numerous expansion opportunities for the growth of the orthopedic market. Lack of orthopedic surgeons and High cost of Implants are estimated to be one of the major factors that are restricting the growth of the orthopedic market across the globe.